Article Details
Retrieved on: 2025-01-16 09:04:40
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AQR Capital Management LLC bought a new position in Protalix BioTherapeutics during the 2nd quarter worth $67,000. Point72 Asia Singapore Pte. Ltd ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here